The DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index.
Effects of Clopidogrel in Addition to Aspirin in Patients with Acute Coronary Syndromes without ST-Segment Elevation
Open accessAbstract
BACKGROUND: Despite current treatments, patients who have acute coronary syndromes without ST-segment elevation have high rates of major vascular events. We evaluated the efficacy and safety of the antiplatelet agent clopidogrel when given with aspirin in such patients. METHODS: We randomly assigned 12,562 patients who had presented within 24 hours after the onset of symptoms to receive clopidogrel (300 mg immediately, followed by 75 mg once daily) (6259 patients) or placebo (6303 patients) in addition to aspirin for 3 to 12 months. RESULTS: The first primary outcome--a composite of death from cardiovascular causes, nonfatal myocardial infarction, or stroke--occurred in 9.3 percent of the patients in the clopidogrel group and 11.4 percent of the patients in the placebo group (relative risk with clopidogrel as compared with placebo, 0.80; 95 percent confidence interval, 0.72 to 0.90; P<0.001). The second primary outcome--the first primary outcome or refractory ischemia--occurred in 16.5 percent of the patients in the clopidogrel group and 18.8 percent of the patients in the placebo group (relative risk, 0.86; 95 percent confidence interval, 0.79 to 0.94; P<0.001). The percentages of patients with in-hospital refractory or severe ischemia, heart failure, and revascularization procedures were also significantly lower with clopidogrel. There were significantly more patients with major bleeding in the clopidogrel group than in the placebo group (3.7 percent vs. 2.7 percent; relative risk, 1.38; P=0.001), but there were not significantly more patients with episodes of life-threatening bleeding (2.2 percent [corrected] vs. 1.8 percent; P=0.13) or hemorrhagic strokes (0.1 percent vs. 0.1 percent). CONCLUSIONS: The antiplatelet agent clopidogrel has beneficial effects in patients with acute coronary syndromes without ST-segment elevation. However, the risk of major bleeding is increased among patients treated with clopidogrel.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“and from 6.4% to 4.5% (P ¼ 0.03) over a period of 8 months in NSTEMI patients [Clopidogrel in Unstable Angina to Prevent Recurrent Events (CURE)].505”
From European Guidelines on cardiovascular disease prevention in clinical practice (version 2012) (2012) · cites this paper as [505]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
(2000) · New England Journal of Medicine · doi:10.1056/nejm200001203420301 · Cited by 8,663
Self-citation(1996) · The Lancet · doi:10.1016/s0140-6736(96)09457-3 · Cited by 6,503
Altman, R., Carreras, L., Díaz, R. S., Figueroa, E. B., Paolasso, E., Parodi, J. C., Cade, J. F., Donnan, G. A., Eadie, M. J., Gavaghan, T. P., et al. (1994) · BMJ · doi:10.1136/bmj.308.6921.81 · Cited by 4,204
The GUSTO-I Investigators (1998) · New England Journal of Medicine · doi:10.1056/nejm199808133390704 · Cited by 1,431
Self-citationThe Platelet Receptor Inhibition in Ischemic Syndrome Management in Patients Limited by Unstable Signs and Symptoms (PRISM-PLUS) Study Investigators (1998) · New England Journal of Medicine · doi:10.1056/nejm199805213382102 · Cited by 1,330
Self-citationRao, A. K., Pratt, C. M., Berke, A. D., Jaffe, A. S., Ockene, I. S., SCHREIBER, T. L., Bell, W. R., Knatterud, G. L., ROBERTSON, T. L., & Terrin, M. L. (1988) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(88)90158-1 · Cited by 979
Low-molecular-weight heparin during instability in coronary artery disease
Fragmin during Instability in Coronary Artery Disease (FRISC) study group (1996) · The Lancet · doi:10.1016/s0140-6736(96)91270-2 · Cited by 683
Wallentin, L. C., Swahn, E., Kontny, F. P., Husted, S., Lagerqvist, B., Ståhle, E., Jd, N., Dellborg, M., Geiran, O. R., Grande, P., et al. (1999) · The Lancet · doi:10.1016/s0140-6736(99)07350-x · Cited by 405
Increased Mortality With Oral Platelet Glycoprotein IIb/IIIa Antagonists
Chew, D. P., Bhatt, D. L., Sapp, S. K., & Topol, E. J. (2001) · Circulation · doi:10.1161/01.cir.103.2.201 · Cited by 359
Flagged first, then by citations
Cited by
Sorted by citations
Items 701–800 of 1,007
Nijjer, S. S., Watson, G., Athanasiou, T., & Malik, I. S. (2011) · European Heart Journal · doi:10.1093/eurheartj/ehr151 · Cited by 107
Columbo, J. A., Lambour, A. J., Sundling, R. A., Chauhan, N. B., Bessen, S. Y., Linshaw, D. L., Kang, R., Riblet, N. B. V., Goodney, P. P., & Stone, D. H. (2017) · Annals of Surgery · doi:10.1097/sla.0000000000002279 · Cited by 106
The platelet P2 receptors as molecular targets for old and new antiplatelet drugs
Gachet, C. (2005) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2005.03.009 · Cited by 105
Pharmacogenetics in Cardiovascular Antithrombotic Therapy
Marín, F. R., Gónzález‐Conejero, R., Capranzano, P., Bass, T. A., Roldán, V., & Angiolillo, D. J. (2009) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2009.04.084 · Cited by 105
Antiplatelet agents for chronic kidney disease
Palmer, S. C., Micco, L. D., Razavian, M., Craig, J. C., Perkovic, V., Pellegrini, F., Jardine, M., Webster, A. C., Zoungas, S., & Strippoli, G. F. (2013) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd008834.pub3 · Cited by 104
Cost-Effectiveness of Genotype-Guided and Dual Antiplatelet Therapies in Acute Coronary Syndrome
Kazi, D. S., Garber, A. M., Shah, R. U., Dudley, R. A., Mell, M. W., Rhee, C., Moshkevich, S., Boothroyd, D. B., Owens, D. K., & Hlatky, M. A. (2014) · Annals of Internal Medicine · doi:10.7326/m13-1999 · Cited by 108
Antiplatelet effects of Cyperus rotundus and its component (+)-nootkatone
Seo, E. J., Lee, D., Kwak, J. H., Lee, S., Kim, Y. S., & Jung, Y. (2011) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2011.02.025 · Cited by 104
Cuisset, T., Loosveld, M., Morange, P., Quilici, J., Moro, P.-J., Saut, N., Gaborit, B., Castelli, C., Beguin, S., Grosdidier, C., et al. (2012) · JACC: Cardiovascular Interventions · doi:10.1016/j.jcin.2012.07.015 · Cited by 104
Wang, T. Y., Xiao, L., Alexander, K. P., Rao, S. V., Kosiborod, M., Rumsfeld, J. S., Spertus, J. A., & Peterson, E. D. (2008) · Circulation · doi:10.1161/circulationaha.108.787143 · Cited by 104
Gurbel, P. A., Fox, K. A. A., Tantry, U. S., Cate, H. T., & Weitz, J. I. (2019) · Circulation · doi:10.1161/circulationaha.118.033580 · Cited by 105
Jinnai, T., Horiuchi, H., Makiyama, T., Tazaki, J., Tada, T., Akao, M., Ono, K., Hoshino, K., Naruse, Y., Takahashi, K., et al. (2009) · Circulation Journal · doi:10.1253/circj.cj-09-0019 · Cited by 104
The pharmacogenetics of carboxylesterases: CES1 and CES2 genetic variants and their clinical effect
Merali, Z., Ross, S., & Paré, G. (2014) · Drug metabolism and drug interactions · doi:10.1515/dmdi-2014-0009 · Cited by 104
Prevalence of aspirin resistance in patients with type 2 diabetes
Fateh‐Moghadam, S., Plöckinger, U., Cabeza, N., Htun, P., Reuter, T., Ersel, S., Gawaz, M., Dietz, R., & Bocksch, W. (2005) · Acta Diabetologica · doi:10.1007/s00592-005-0186-y · Cited by 104
Platelet Function Under Aspirin, Clopidogrel, and Both After Ischemic Stroke
Grau, A., Reiners, S., Lichy, C., Buggle, F., & Ruf, A. (2003) · Stroke · doi:10.1161/01.str.0000064326.65899.ac · Cited by 104
Aspirin and Clopidogrel Resistance
Michos, E. D., Ardehali, R., Blumenthal, R. S., Lange, R. A., & Ardehali, H. (2006) · Mayo Clinic Proceedings · doi:10.4065/81.4.518 · Cited by 104
Vivekananthan, D. P., Bhatt, D. L., Chew, D. P., Zidar, F. J., Chan, A. W., Moliterno, D. J., Ellis, S. G., & Topol, E. J. (2004) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2004.04.035 · Cited by 104
Li, Y., Tang, H., Hu, Y., & Xie, H. (2011) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2011.04570.x · Cited by 103
Abraham, N. S., Hartman, C. M., Richardson, P., Castillo, D. L., Street, R. L., & Naik, A. D. (2013) · Circulation · doi:10.1161/circulationaha.113.004747 · Cited by 103
Medical Therapy for Long-Term Prevention of Atherothrombosis Following an Acute Coronary Syndrome
Gallone, G., Baldetti, L., Pagnesi, M., Latib, A., Colombo, A., Libby, P., & Giannini, F. (2018) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2018.09.052 · Cited by 104
Ng, F., Wong, S., Lam, K., Chang, C.-M., Lau, Y., Chu, W., & Yu, W. B. C. (2008) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2007.01715.x · Cited by 103
Does clopidogrel affect outcome after coronary artery bypass grafting? A meta-analysis: Table 1
Purkayastha, S., Athanasiou, T., Malinovski, V., Tekkis, P., Foale, R., Casula, R., Glenville, B., & Darzi, A. W. (2006) · Heart · doi:10.1136/hrt.2004.058396 · Cited by 103
Antiplatelet Therapy for Ischemic Heart Disease
Lange, R. A., & Hillis, L. D. (2004) · New England Journal of Medicine · doi:10.1056/nejme038191 · Cited by 103
Cangrelor: a review on its mechanism of action and clinical development
Ferreiro, J. L., Ueno, M., & Angiolillo, D. J. (2009) · Expert Review of Cardiovascular Therapy · doi:10.1586/erc.09.101 · Cited by 102
Sorich, M. J., Vitry, A. I., Ward, M., Horowitz, J. D., & McKinnon, R. A. (2010) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2010.03923.x · Cited by 102
Shehab, N., Sperling, L. S., Kegler, S. R., & Budnitz, D. S. (2010) · Archives of Internal Medicine · doi:10.1001/archinternmed.2010.407 · Cited by 102
Kosuge, M., Kimura, K., Ishikawa, T., Ebina, T., Shimizu, T., Hibi, K., Toda, N., Tahara, Y., Tsukahara, K., Kanna, M., et al. (2005) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2005.01.085 · Cited by 102
Bueno, H., Bardajı́, A., Fernández‐Ortíz, A., Marrugat, J., Martí-Soler, H., & Heras, M. (2005) · Revista Española de Cardiología · doi:10.1157/13072471 · Cited by 102
Antithrombotic Therapy in Patients With Saphenous Vein and Internal Mammary Artery Bypass Grafts
Stein, P. D., Schünemann, H. J., Dalen, J. E., & Gutterman, D. D. (2004) · CHEST Journal · doi:10.1378/chest.126.3_suppl.600s · Cited by 102
Platelets and Anti-platelet Therapy
McNicol, A., & Israels, S. J. (2003) · Journal of Pharmacological Sciences · doi:10.1254/jphs.93.381 · Cited by 102
Heart Failure in the Twenty-First Century: Is it a Coronary Artery Disease or Hypertension Problem?
Velagaleti, R. S., & Vasan, R. S. (2007) · Cardiology Clinics · doi:10.1016/j.ccl.2007.08.010 · Cited by 106
Borna, C., Lazarowski, E. R., van Heusden, C. A., Öhlin, H., & Erlinge, D. (2005) · Thrombosis Journal · doi:10.1186/1477-9560-3-10 · Cited by 101
Davidson, J. C., Rahim, S., Hanks, S. E., Patel, I. J., Tam, A. L., Walker, T. G., Weinberg, I., Wilkins, L. R., & Sarode, R. (2019) · Journal of Vascular and Interventional Radiology · doi:10.1016/j.jvir.2019.04.016 · Cited by 103
Angiolillo, D. J., Fernández‐Ortíz, A., Bernardo, E., Alfonso, F., Sabaté, M., Fernández, C., Stranieri, C., Trabetti, E., Pignatti, P. F., & Macaya, C. (2004) · Blood Coagulation & Fibrinolysis · doi:10.1097/00001721-200401000-00014 · Cited by 101
Ly, H. Q., Kirtane, A. J., Murphy, S. A., Buros, J., Cannon, C. P., D, E. B. M., & Gibson, C. M. (2006) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2006.01.046 · Cited by 101
Eikelboom, J. W., & Hankey, G. J. (2003) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(02)03013-9 · Cited by 101
The evolution of antiplatelet therapy in cardiovascular disease
Yousuf, O. K., & Bhatt, D. L. (2011) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2011.96 · Cited by 103
Kushner, F. G., Hand, M. M., Smith, S. C., King, S. B., Anderson, J. L., Antman, E. M., Bailey, S. R., Bates, E., Blankenship, J. C., Casey, D. E., et al. (2009) · Catheterization and Cardiovascular Interventions · doi:10.1002/ccd.22351 · Cited by 101
Woodward, M., Lowe, G. D. O., Francis, L., Rumley, A., & Cobbe, S. M. (2004) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2004.01017.x · Cited by 100
Schleinitz, M. D., & Heidenreich, P. A. (2005) · Annals of Internal Medicine · doi:10.7326/0003-4819-142-4-200502150-00007 · Cited by 98
Medical Treatment of Peripheral Arterial Disease: A Comprehensive Review
Stoyioglou, A., & Jaff, M. R. (2004) · Journal of Vascular and Interventional Radiology · doi:10.1097/01.rvi.0000137978.15352.c6 · Cited by 99
Hobson, A. R., Agarwala, R. A., Swallow, R. A., Dawkins, K. D., & Curzen, N. P. (2006) · Platelets · doi:10.1080/09537100600935259 · Cited by 100
Elimination of the Left Atrial Appendage To Prevent Stroke or Embolism?
Stöllberger, C., Schneider, B., & Finsterer, J. (2003) · CHEST Journal · doi:10.1378/chest.124.6.2356 · Cited by 100
Patel, M. R., Becker, R. C., WOJDYLA, D. M., Emanuelsson, H., Hiatt, W. R., Horrow, J. C., Husted, S., Mahaffey, K. W., Steg, P. G., Storey, R. F., et al. (2014) · European Journal of Preventive Cardiology · doi:10.1177/2047487314533215 · Cited by 100
Lawesson, S. S., Alfredsson, J., Fredrikson, M. G., & Swahn, E. (2012) · BMJ Open · doi:10.1136/bmjopen-2011-000726 · Cited by 99
Soffer, D. E., Moussa, I. D., Harjai, K. J., Boura, J., Dixon, S. R., Grines, C. L., O’Neill, W. W., Roubin, G. S., & Moses, J. W. (2003) · Catheterization and Cardiovascular Interventions · doi:10.1002/ccd.10494 · Cited by 99
Kang, H.-S., Kwon, B. J., Kim, J. E., & Han, M. H. (2010) · American Journal of Neuroradiology · doi:10.3174/ajnr.a2051 · Cited by 99
The ACTIVE Steering Committee (2006) · American Heart Journal · doi:10.1016/j.ahj.2005.06.026 · Cited by 99
Predicting Clopidogrel Response Using DNA Samples Linked to an Electronic Health Record
Delaney, J. T., Ramirez, A. H., Bowton, E., Pulley, J. M., Basford, M., Schildcrout, J. S., Shi, Y., Zink, R., Oetjens, M. T., Xu, H., et al. (2011) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2011.221 · Cited by 99
Zakko, L., Rustagi, T., Douglas, M., & Laine, L. (2016) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2016.07.017 · Cited by 99
Gorog, D. A., Ferreiro, J. L., Ahrens, I., Ako, J., Geisler, T., Halvorsen, S., Huber, K., Jeong, Y., Navarese, E. P., Rubboli, A., et al. (2023) · Nature Reviews Cardiology · doi:10.1038/s41569-023-00901-2 · Cited by 100
2024 EACTS Guidelines on perioperative medication in adult cardiac surgery
Jeppsson, A., (Sweden), (.-C., Rocca, B., (Italy), (.-C., Hansson, E. C., (Sweden), Guðbjartsson, T., (Iceland), James, S. K., (Sweden), et al. (2024) · European Journal of Cardio-Thoracic Surgery · doi:10.1093/ejcts/ezae355 · Cited by 114
Frontera, J. A., Egorova, N., & Moskowitz, A. J. (2011) · Critical Care Medicine · doi:10.1097/ccm.0b013e3182186ed6 · Cited by 101
Fanning, J. P., Nyong, J., Scott, I. A., Aroney, C. N., & Walters, D. (2016) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004815.pub4 · Cited by 97
Carrizzo, A., Izzo, C., Oliveti, M., Alfano, A., Virtuoso, N., Capunzo, M., Pietro, P. D., Calabrese, M., Simone, E. D., Sciarretta, S., et al. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19102968 · Cited by 106
Impact of clopidogrel in coronary artery bypass grafting1
Englberger, L., FAEH, B., Berdat, P. A., Eberli, F. R., Meier, B., & CARREL, T. (2004) · European Journal of Cardio-Thoracic Surgery · doi:10.1016/j.ejcts.2004.03.030 · Cited by 98
Grodzinsky, A., Arnold, S. V., GOSCH, K. L., Spertus, J. A., Foody, J. M., Beltrame, J. F., Maddox, T. M., Parashar, S., & Kosiborod, M. (2015) · European Heart Journal - Quality of Care and Clinical Outcomes · doi:10.1093/ehjqcco/qcv014 · Cited by 97
Bellemain-Appaix, A., Kernéis, M., O’Connor, S. A., Silvain, J., Cucherat, M., Beygui, F., Barthélémy, O., Collet, J. ‐., Jacq, L., Bernasconi, F., et al. (2014) · BMJ · doi:10.1136/bmj.g6269 · Cited by 97
Antiplatelet and Anticoagulation Therapy for Acute Coronary Syndromes
Bhatt, D. L., Hulot, J., Moliterno, D. J., & Harrington, R. A. (2014) · Circulation Research · doi:10.1161/circresaha.114.302737 · Cited by 96
Bhatt, D. L., Paré, G., Eikelboom, J. W., Simonsen, K. L., Emison, E., Fox, K. A. A., Steg, P. G., Montalescot, G., Bhakta, N., Hacke, W., et al. (2012) · European Heart Journal · doi:10.1093/eurheartj/ehs059 · Cited by 97
“Triple Therapy” Rather Than “Triple Threat”
Zhao, H., Zheng, Z., Wang, Z., Li, S., Zhang, Y., Zhong, M., & Zhang, W. (2011) · CHEST Journal · doi:10.1378/chest.09-3083 · Cited by 97
Quantifying the Effect of Antiplatelet Therapy
Agarwal, S., Coakely, M., Reddy, K., Riddell, A. F., & Mallett, S. (2006) · Anesthesiology · doi:10.1097/00000542-200610000-00011 · Cited by 97
Mehta, S. R., & Yusuf, S. (2003) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(02)02831-0 · Cited by 97
Guía europea de prevención cardiovascular en la práctica clínica: Adaptación española del CEIPC 2008
Lobos, J. M., Royo‐Bordonada, M. Á., Brotons, C., Álvarez-Sala, L., Armario, P., Maiques, A., Mauricio, D., Sans, S., Villar, F., Lizcano‐Álvarez, A., et al. (2008) · Revista Española de Salud Pública · doi:10.1590/s1135-57272008000600002 · Cited by 97
Hong, S. J., Kim, M. H., Ahn, T. H., Ahn, Y. K., Bae, J., Shim, W. J., Ro, Y. M., & Lim, D.-S. (2006) · Heart · doi:10.1136/hrt.2005.075960 · Cited by 97
Antiplatelet drug 'resistance'. Part 1: mechanisms and clinical measurements
Sweeny, J. M., Gorog, D. A., & Fuster, V. (2009) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2009.10 · Cited by 96
Biancari, F., Airaksinen, J. K. E., & Lip, G. Y. H. (2011) · Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/j.jtcvs.2011.01.069 · Cited by 96
Moll, F. L., Baumgärtner, I., Jaff, M. R., Nwachuku, C., Tangelder, M. J. D., Ansel, G. M., Adams, G. L., Zeller, T., Rundback, J. H., GROSSO, M. A., et al. (2018) · Journal of Endovascular Therapy · doi:10.1177/1526602818760488 · Cited by 100
Hsu, P., Lai, K., & Liu, C. (2010) · Gastroenterology · doi:10.1053/j.gastro.2010.11.056 · Cited by 96
The Efficacy and Safety of Perioperative Antiplatelet Therapy
Merritt, J., & Bhatt, D. L. (2004) · Journal of Thrombosis and Thrombolysis · doi:10.1023/b:thro.0000036025.07348.f1 · Cited by 96
Kosoglou, T., Reyderman, L., Tiessen, R. G., van Vliet, A. A., Fales, R. R., Keller, R., Yang, B., & Cutler, D. L. (2011) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-011-1120-6 · Cited by 97
Recent Safety Concerns With Proton Pump Inhibitors
Chen, J. W., Yuan, Y., Leontiadis, G. I., & Howden, C. W. (2012) · Journal of Clinical Gastroenterology · doi:10.1097/mcg.0b013e3182333820 · Cited by 95
Gibson, C. M., Mega, J. L., Burton, P. B. J., Goto, S., Verheugt, F. W. A., Bode, C., Plotnikov, A. N., Sun, X., Cook‐Bruns, N., & Braunwald, E. (2011) · American Heart Journal · doi:10.1016/j.ahj.2011.01.026 · Cited by 96
Effect of P2Y12 inhibitors on inflammation and immunity
Storey, R. F., & Thomas, M. (2015) · Thrombosis and Haemostasis · doi:10.1160/th14-12-1068 · Cited by 95
van den Anker, J. N., McCune, S., Annaert, P., Baer, G., Mulugeta, Y. A., Abdelrahman, R. A., Wu, K., Krudys, K. M., Fisher, J. W., Slikker, W., et al. (2020) · Pharmaceutics · doi:10.3390/pharmaceutics12070685 · Cited by 95
The vulnerable plaque and acute coronary syndromes
Corti, R., Farkouh, M. E., & Badimón, J. J. (2002) · The American Journal of Medicine · doi:10.1016/s0002-9343(02)01344-x · Cited by 95
Sane, D. C., McKee, S., Malinin, A. I., & Serebruany, V. L. (2002) · The American Journal of Cardiology · doi:10.1016/s0002-9149(02)02718-2 · Cited by 95
van der Linden, J., Lindvall, G., & Sartipy, U. (2005) · Circulation · doi:10.1161/circulationaha.104.524611 · Cited by 95
Platelet glycoprotein IIb/IIIa inhibitors in acute coronary syndromes
Boersma, E. H., Harrington, R. A., Moliterno, D. J., White, H. D., & Simoons, M. L. (2002) · The Lancet · doi:10.1016/s0140-6736(02)09532-6 · Cited by 95
Boggon, R., van Staa, T. P., Timmis, A., Hemingway, H., Ray, K. K., Begg, A. G., Emmas, C., & Fox, K. A. A. (2011) · European Heart Journal · doi:10.1093/eurheartj/ehr340 · Cited by 94
Antiplatelet Therapy Duration Following Bare Metal or Drug-Eluting Coronary Stents
Kereiakes, D. J., Yeh, R. W., Massaro, J. M., Driscoll-Shempp, P., Cutlip, D. E., Steg, P. G., Gershlick, A., Darius, H., Meredith, I. T., Ormiston, J. A., et al. (2015) · JAMA · doi:10.1001/jama.2015.1671 · Cited by 94
Aspect of Thrombolytic Therapy: A Review
Ali, M. R., Hossain, M. S., Islam, M. A., Arman, M. S. I., Raju, G. S., Dasgupta, P., & Noshin, T. F. (2014) · The Scientific World JOURNAL · doi:10.1155/2014/586510 · Cited by 94
Epidemiology of Multimorbidity in Older Adults with Cardiovascular Disease
Bell, S. P., & Saraf, A. A. (2016) · Clinics in Geriatric Medicine · doi:10.1016/j.cger.2016.01.013 · Cited by 94
Brown, M. D., Wolf, S. J., Byyny, R. L., Diercks, D. B., Gemme, S. R., Gerardo, C. J., Godwin, S. A., Hahn, S. A., Harrison, N. E., Hatten, B. W., et al. (2018) · Annals of Emergency Medicine · doi:10.1016/j.annemergmed.2018.07.045 · Cited by 97
Roffi, M. (2004) · European Heart Journal · doi:10.1016/j.ehj.2003.10.027 · Cited by 94
2011 ACCF/AHA Guideline for Coronary Artery Bypass Graft Surgery: Executive Summary
Hillis, L. D., Smith, P. K., Anderson, J. L., Bittl, J. A., Bridges, C. R., Byrne, J. G., Cigarroa, J. E., DiSesa, V. J., Hiratzka, L. F., Hutter, A. M., et al. (2011) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2011.08.008 · Cited by 98
Gaitonde, R. S., Sharma, N., Ali-Hasan, S., Miller, J. M., Jayachandran, J. V., & Kalaria, V. G. (2003) · The American Journal of Cardiology · doi:10.1016/s0002-9149(03)00898-1 · Cited by 94
Byrne, R. A., Schulz, S., Mehilli, J., Iijima, R., Maßberg, S., Neumann, F., Berg, J. M. T., Schömig, A., & Kastrati, A. (2009) · American Heart Journal · doi:10.1016/j.ahj.2008.12.019 · Cited by 93
Varenhorst, C., James, S. K., Erlinge, D., Braun, O. Ö., Brandt, J. T., Winters, K. J., Jakubowski, J. A., Olofsson, S., Wallentin, L. C., & Siegbahn, A. G. (2009) · American Heart Journal · doi:10.1016/j.ahj.2008.11.021 · Cited by 93
Platelet ADP-receptor antagonists for cardiovascular disease: past, present and future
Raju, N. C., Eikelboom, J. W., & Hirsh, J. (2008) · Nature Clinical Practice Cardiovascular Medicine · doi:10.1038/ncpcardio1372 · Cited by 94
Schleinitz, M. D., Weiss, J. P., & Owens, D. K. (2004) · The American Journal of Medicine · doi:10.1016/j.amjmed.2004.01.014 · Cited by 93
Gomez, Y., Adams, E., & Hoogmartens, J. (2003) · Journal of Pharmaceutical and Biomedical Analysis · doi:10.1016/s0731-7085(03)00533-8 · Cited by 93
Pollack, C. V., & D, E. B. M. (2007) · Annals of Emergency Medicine · doi:10.1016/j.annemergmed.2007.09.004 · Cited by 93
Antiplatelet Agents in the Perioperative Period
O’Riordan, J. M. (2009) · Archives of Surgery · doi:10.1001/archsurg.144.1.69 · Cited by 93
Aspirin and Clopidogrel in Acute Coronary Syndromes
Jneid, H. M., Bhatt, D. L., Corti, R., Badimon, J. J., Fuster, V., & Francis, G. S. (2003) · Archives of Internal Medicine · doi:10.1001/archinte.163.10.1145 · Cited by 93
Medical Management After Coronary Stent Implantation
Brilakis, E. S., PATEL, V. G., & Banerjee, S. (2013) · JAMA · doi:10.1001/jama.2013.7086 · Cited by 93
Focks, J. J., Brouwer, M. A., van Oijen, M. G. H., Lanas, Á., Bhatt, D. L., & Verheugt, F. W. A. (2012) · Heart · doi:10.1136/heartjnl-2012-302371 · Cited by 92
Schunkert, H., Boening, A., von Scheidt, M., Lanig, C., Gusmini, F., de Waha, A., Kuna, C., Fach, A., Grothusen, C., Oberhoffer, M. M., et al. (2019) · European Heart Journal · doi:10.1093/eurheartj/ehz185 · Cited by 96
Bivalirudin: A direct thrombin inhibitor
Gladwell, T. D. (2002) · Clinical Therapeutics · doi:10.1016/s0149-2918(02)85004-4 · Cited by 92
Advances in Antiplatelet Therapy: Agents in Clinical Development
Angiolillo, D. J., Bhatt, D. L., Gurbel, P. A., & Jennings, L. K. (2009) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2008.11.023 · Cited by 92
Sherwood, M. W., Wiviott, S. D., Peng, S. A., Roe, M. T., deLemos, J. A., Peterson, E. D., & Wang, T. Y. (2014) · Journal of the American Heart Association · doi:10.1161/jaha.114.000849 · Cited by 91
Metadata
- Authors
- The Clopidogrel in Unstable Angina to Prevent Recurrent Events Trial Investigators
- Affiliations
- Hamilton General Hospital (CA)
- Corresponding author
- The Clopidogrel in Unstable Angina to Prevent Recurrent Events Trial Investigators
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2001-08-16
- Volume
- 345
- Issue
- 7
- Pages
- 494-502
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W1553345686
- Cited by
- 6,470
- References
- 16
- Citations by year
- 2026: 63 · 2025: 99 · 2024: 77 · 2023: 110 · 2022: 121 · 2021: 163 · 2020: 168 · 2019: 202 · 2018: 216 · 2017: 229 · 2016: 265 · 2015: 325 · 2014: 319 · 2013: 397 · 2012: 395
- FWCI
- 178.22
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Repository of the Academy's Library (Library of the Hungarian Academy of Sciences) (acceptedVersion)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Antiplatelet Therapy and Cardiovascular Diseases
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Acute Myocardial Infarction Research
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Coronary Interventions and Diagnostics
- Keywords
- clopidogrel, aspirin, antiplatelet therapy, major bleeding, refractory ischemia, cardiovascular mortality, myocardial infarction, stroke, heart failure, revascularization
- MeSH terms
- Clopidogrel, Acute Disease, Aged, Aspirin, Cardiovascular Diseases, Drug Therapy, Combination, Electrocardiography, Female, Hemorrhage, Humans, Male, Middle Aged, Platelet Aggregation Inhibitors, Risk Factors, Ticlopidine, Myocardial Ischemia
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
